Generic Drug Pathway Curriculum: From ANDA Submission to Global Reliance
AI Overview
FDA sources sought for Global Abbreviated New Drug Application (ANDA) training program curriculum and services. Five-year contract with four option years; training development and delivery.
This summary is AI-generated from the official solicitation.
Key Details
Official Description
The U.S. Food and Drug Administration's (FDA), Office of Acquisitions and Grants Services (OAGS), is conducting market research for obtaining Global Abbreviated New Drug Application (ANDA) Training Program services. THIS IS A SOURCES SOUGHT NOTICE (SSN) ONLY. This SSN is being issued in accordance with Federal Acquisition Regulation (FAR) Part 10, Market Research. It is for information, planning, and market research purposes only and is not to be construed as a commitment by the Government to is...
Change History
Generic Drug Pathway Curriculum: From ANDA Submission to Global Reliance
New SAM.gov opportunity: Generic Drug Pathway Curriculum: From ANDA Submission to Global Reliance
Similar Opportunities
Get Alerts for Opportunities Like This
RallyProp monitors thousands of funding sources and sends instant alerts when opportunities match your technology and capabilities.
Start Free Trial